South Carolina General Assembly
123rd Session, 2019-2020

Download This Bill in Microsoft Word format

Indicates Matter Stricken
Indicates New Matter

H. 4355

STATUS INFORMATION

General Bill
Sponsors: Reps. Fry, Yow, Hewitt, Bailey, Wooten, Erickson, Pendarvis, Weeks and Dillard
Document Path: l:\council\bills\cc\15547vr19.docx

Introduced in the House on March 28, 2019
Currently residing in the House Committee on Medical, Military, Public and Municipal Affairs

Summary: Methadone restrictions

HISTORY OF LEGISLATIVE ACTIONS

     Date      Body   Action Description with journal page number
-------------------------------------------------------------------------------
   3/28/2019  House   Introduced and read first time (House Journal-page 50)
   3/28/2019  House   Referred to Committee on Medical, Military, Public and 
                        Municipal Affairs (House Journal-page 50)

View the latest legislative information at the website

VERSIONS OF THIS BILL

3/28/2019

(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)

A BILL

TO AMEND SECTION 44-53-720, CODE OF LAWS OF SOUTH CAROLINA, 1976, RELATING TO RESTRICTIONS ON THE USE OF METHADONE, SO AS TO AUTHORIZE PHARMACISTS AND NURSES TO ADMINISTER OR DISPENSE METHADONE OR OTHER OPIOID AGONIST TREATMENT MEDICATIONS IN CERTAIN CIRCUMSTANCES.

Be it enacted by the General Assembly of the State of South Carolina:

SECTION    1.    Section 44-53-720 of the 1976 Code is amended to read:

"Section 44-53-720.    (A)    Methadone and its salts are restricted to:

(1)    use in treatment, maintenance, or detoxification programs as approved by the Department of Health and Environmental Control.;

(2)    dispensing by a hospital for analgesia, pertussis, and detoxification treatment as approved by the Department of Health and Environmental Control.; and

(3)    dispensing by a retail pharmacy for analgesia as provided for by R. 61-4, Section 507.5 1012.

(B)    Methadone or any other opioid agonist treatment medication that is approved by the Food and Drug Administration pursuant to 21 U.S.C. Section 355 for use in the treatment of opioid use disorder must be administered or dispensed only by a practitioner licensed by the State Board of Medical Examiners and registered under state and federal law to administer or dispense opioid drugs, or by an agent of such a practitioner, supervised by or under the order of the licensed practitioner. The agent must be a pharmacist, registered nurse, or licensed practical nurse authorized by federal and state law to administer or dispense opioid drugs and employed by the program, hospital, or pharmacy dispensing the treatment medication."

SECTION    2.    This act takes effect upon approval by the Governor.

----XX----


This web page was last updated on March 29, 2019 at 4:04 PM